Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Treatment non-response in OCD: methodological issues and operational definitions.

Pallanti S, Hollander E, Bienstock C, Koran L, Leckman J, Marazziti D, Pato M, Stein D, Zohar J; International Treatment Refractory OCD Consortium.

Int J Neuropsychopharmacol. 2002 Jun;5(2):181-91. Review.

PMID:
12135542
2.

Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines.

Pallanti S, Quercioli L.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):400-12. Epub 2006 Feb 28. Review.

PMID:
16503369
3.

Clinical predictors of drug nonresponse in obsessive-compulsive disorder.

Shetti CN, Reddy YC, Kandavel T, Kashyap K, Singisetti S, Hiremath AS, Siddequehusen MU, Raghunandanan S.

J Clin Psychiatry. 2005 Dec;66(12):1517-23.

PMID:
16401151
4.

Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder.

Stein DJ, Spadaccini E, Hollander E.

Int Clin Psychopharmacol. 1995 Mar;10(1):11-8.

PMID:
7622800
5.

The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.

Shavitt RG, Valério C, Fossaluza V, da Silva EM, Cordeiro Q, Diniz JB, Belotto-Silva C, Cordioli AV, Mari J, Miguel EC.

Eur Arch Psychiatry Clin Neurosci. 2010 Mar;260(2):91-9. doi: 10.1007/s00406-009-0015-3.

PMID:
20077119
6.

[Critical analysis of controlled pharmacologic studies in obsessive compulsive disorder].

Brochier T, Hantouche E.

Encephale. 1989 May-Jun;15(3):325-33. Review. French.

PMID:
8641159
7.

Pharmacological management of obsessive-compulsive disorder: a review for clinicians.

McDonough M, Kennedy N.

Harv Rev Psychiatry. 2002 May-Jun;10(3):127-37. Review.

PMID:
12023928
8.

Pharmacologic therapy of obsessive compulsive disorder.

DeVeaugh-Geiss J.

Adv Pharmacol. 1994;30:35-52. Review.

PMID:
7833296
9.

The use of psychotropic agents for the symptoms of obsessive-compulsive disorder.

Brakoulias V, Starcevic V, Berle D, Milicevic D, Moses K, Hannan A, Sammut P, Martin A.

Australas Psychiatry. 2013 Apr;21(2):117-21. doi: 10.1177/1039856212470502. Epub 2013 Feb 20.

PMID:
23426097
10.

[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].

Nakamae T.

Seishin Shinkeigaku Zasshi. 2011;113(10):1016-25. Review. Japanese.

PMID:
22187889
11.

Clinical predictors of response to pharmacotherapy with selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

Tükel R, Bozkurt O, Polat A, Genç A, Atli H.

Psychiatry Clin Neurosci. 2006 Aug;60(4):404-9.

12.

Issues in the pharmacological treatment of obsessive-compulsive disorder.

Math SB, Janardhan Reddy YC.

Int J Clin Pract. 2007 Jul;61(7):1188-97. Epub 2007 May 18. Review.

PMID:
17511795
13.

[Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].

Ammar G, Naja WJ, Pelissolo A.

Encephale. 2015 Jun;41(3):260-5. doi: 10.1016/j.encep.2013.11.002. Epub 2014 Nov 14. Review. French.

PMID:
25439852
14.

Pharmacotherapy for obsessive-compulsive disorder.

Dougherty DD, Rauch SL, Jenike MA.

J Clin Psychol. 2004 Nov;60(11):1195-202.

PMID:
15389617
15.

The medical treatment of obsessive-compulsive disorder and anxiety.

Bandelow B.

CNS Spectr. 2008 Sep;13(9 Suppl 14):37-46. Review.

PMID:
18849910
16.

Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials?

Geller DA, Biederman J, Stewart SE, Mullin B, Farrell C, Wagner KD, Emslie G, Carpenter D.

J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S19-29.

PMID:
12880497
17.

Comparison of clinical characteristics and comorbidity in schizophrenia patients with and without obsessive-compulsive disorder: schizophrenic and OC symptoms in schizophrenia.

Poyurovsky M, Kriss V, Weisman G, Faragian S, Kurs R, Schneidman M, Fuchs C, Weizman A, Weizman R.

J Clin Psychiatry. 2003 Nov;64(11):1300-7.

PMID:
14658943
18.

Pharmacotherapy in paediatric obsessive-compulsive disorder: a naturalistic, retrospective study.

Masi G, Millepiedi S, Perugi G, Pfanner C, Berloffa S, Pari C, Mucci M.

CNS Drugs. 2009;23(3):241-52. doi: 10.2165/00023210-200923030-00005.

PMID:
19320532
19.

Obsessive-compulsive disorder with poor insight: a three-year prospective study.

Catapano F, Perris F, Fabrazzo M, Cioffi V, Giacco D, De Santis V, Maj M.

Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):323-30. doi: 10.1016/j.pnpbp.2009.12.007. Epub 2009 Dec 16.

PMID:
20015461
20.

Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD).

Soomro GM, Altman D, Rajagopal S, Oakley-Browne M.

Cochrane Database Syst Rev. 2008 Jan 23;(1):CD001765. doi: 10.1002/14651858.CD001765.pub3. Review.

PMID:
18253995

Supplemental Content

Support Center